Early Nodular Hyperplasia of the Liver Occurring with Inflammatory Bowel Diseases in Association with Thioguanine Therapy

Archives of Pathology and Laboratory Medicine

Volumn 128, Issue 1, 2004, Pages 49-53

  Shastri, Sunita ^a   Dubinsky, Marla C ^a   Poordad, F Fred ^a   Vasiliauskas, Eric A ^a   Geller, Stephen A ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME; TIOGUANINE;

ADULT; ARTICLE; ENTERITIS; ENZYME BLOOD LEVEL; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER HYPERPLASIA; MALE; NODULAR HYPERPLASIA; PERCUTANEOUS BIOPSY; SILVER IMPREGNATION;

ADULT; HUMANS; HYPERPLASIA; INFLAMMATORY BOWEL DISEASES; LIVER; MALE; THIOGUANINE;

EID: 0346998117     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Sabourin C. La glande biliare et l'hyperplasie nodulaire du foie. Rev de Méd. 1884;4:322-333.
2. Steiner PE. Nodular regenerative hyperplasia of the liver. Am J Pathol. 1959; 35:943-953.
3. Stromeyer FW, Ishak KG. Nodular transformation (nodular regenerative hyperplasia) of the liver: a clinicopathologic study of 30 cases. Hum Pathol. 1981; 12:60-71.
4. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology. 1990;11:787-797.
5. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology. 1995;22:983-993.
6. Arvanitaki M, Adler M. Nodular regenerative hyperplasia of the liver: a review of 14 cases. Hepatogastroenterology. 2001;48:1425-1429.
7. Gane E, Portmann B, Saxena R, Wong P, Ramage J, Williams R. Nodular regenerative hyperplasia of the liver graft after liver transplantation. Hepatology. 1994;20:88-94.
8. Colina F, Alberti N, Solis JA, Martinez-Tello FJ. Diffuse nodular regenerative hyperplasia of the liver (DNRH): a clinicopathologic study of 24 cases. Liver. 1989;9:253-265.
9. Colina F, Pinedo F, Solis JA, Moreno D, Nevado M. Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis. Gastroenterology. 1992;102:1319-1324.
10. Elariny HA, Mizrahi SS, Hayes DH, Boudreaux JP, Hussey JL, Farr GH Jr. Nodular regenerative hyperplasia: a controversial indication for orthotopic liver transplantation. Transpl Int. 1994;7:309-313.
11. Forbes GM, Shilkin KB, Reed WD. Nodular regenerative hyperplasia of the liver: the importance of combined macroscopic and microscopic findings. Med J Aust. 1991;154:415-417.
12. Harada A, Nakanuma U, Govindarajan S, Peters SL. Nodular regenerative hyperplasia of the liver with and without portal hypertension: a comparison. Ann Clin Lab Sci. 1986;16:155-162.
13. Kobayashi S, Saito K, Nakanuma Y. Nodular regenerative hyperplasia of the liver in hepatocellular carcinoma. J Clin Gastroenterol. 1993;16:155-159.
14. McDonald JA, Painter DM, Gallagher ND, McCaughan GW. Nodular regenerative hyperplasia mimicking cirrhosis of the liver. Gut. 1990;31:725-727.
15. Mones JM, Saldana MJ, Albores-Saavedra J. Nodular regenerative hyperplasia of the liver. Arch Pathol Lab Med. 1984;108:741-743.
16. Motoori S, Shinozaki M, Goto N, Kondo F. Case report: congenital absence of the portal vein associated with nodular hyperplasia in the liver. J Gastroenterol Hepatol. 1997;12:639-643.
17. Naber AHJ, Van Haelst U, Yap SH. Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients. J Hepatol. 1991;12:94-99.
18. Nakanuma Y. Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J Clin Gastroenterol. 1990;12:460-465.
19. Nakanuma Y. Non-neoplastic nodular lesions in the liver. Pathol Int. 1995; 45:703-714.
20. Rha SE, Lee MG, Lee YS, et al. Nodular regenerative hyperplasia of the liver in Budd-Chiari syndrome: CT and MR features. Abdom Imaging. 2000;25: 255-258.
21. Rougier P, Degott C, Rueff B, Benhamou J-P. Nodular regenerative hyperplasia of the liver. Gastroenterology. 1978;75:169-172.
22. Ruiz FP, Martinez FJO, Mendoza ACZ, del Arbol LR, Caparros AM. Nodular regenerative hyperplasia of the liver in rheumatic diseases: report of seven cases and review of the literature. Semin Arthritis Rheum. 1991;21:47-54.
23. Wanless I, Godwin T, Allen F, Feder A. Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. Medicine. 1980;80:267-279.
24. Wanless IR, Gryfe A. Nodular transformation of the liver in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med. 1986;110:331-335.
25. Wanless IR. Portal vein thrombosis is associated with large regenerative nodules and diffuse nodular hyperplasia in cirrhotic livers. Hepatology. 1994;20: 412A.
26. Washington K, Lane KL, Meyers WC. Nodular regenerative hyperplasia in partial hepatectomy specimens. Am J Surg Pathol. 1993;17:1151-1158.
27. Weinbren K, Mutum SS. Pathological aspects of diffuse nodular hyperplasia of the liver. J Pathol. 1984; 143:81-92.
28. Young ID, Segura J, Ford PM, Ford SE. The pathogenesis of nodular regenerative hyperplasia of the liver associated with rheumatoid arthritis. J Clin Gastroenterol. 1992;14:127-131.
29. Gane E, Portmann B, Saxena R, et al. Nodular regenerative hyperplasia of the liver graft after liver transplantation. Hepatology. 1994;20:88-94.
30. Sebagh M, Farges O, Samuel D, Bismuth H, Reynes M. Nodular regenerative hyperplasia of the liver following orthotopic liver transplantation. Transpl Proc. 1995;27:2510-2511.
31. Adler M, Delhaye M, Deprez C, et al. Hepatic vascular disease after kidney transplantation: report of two cases and review of the literature. Nephrol Dial Transplant. 1987;2:183-188.
32. Farthing MJG, Clark ML, Sloane JP, Powles RL, McElwain TJ. Liver disease after bone marrow transplantation. Gut. 1982;23:465-474.
33. Snover DC, Weisdorf S, Bloomer J, et al. Nodular regenerative hyperplasia of the liver following bone marrow transplantation. Hepatology. 1989;9:443-448.
34. Moran CA, Mullick FG, Ishak KG. Nodular regenerative hyperplasia of the liver in children. Am J Surg Pathol. 1991;15:449-454.
35. Galdeano S, Drut R. Nodular regenerative hyperplasia of fetal liver. Pediatr Pathol. 1991;11:479-485.
36. Kondo F. Benign nodular hepatocellular lesions caused by abnormal hepatic circulation: etiological analysis and introduction of a new concept. J Gastroenterol Hepatol. 2001;16:1319-1320.
37. Wanless IR. Vascular disorders. In: MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP, eds. Pathology of the Liver. 4th ed. London, England: Churchill Livingstone; 2002:539-576.
38. Gill RA, Onstad GR, Cardamone JM, et al. Hepatic veno-occlusive disease caused by 6-thioguanine. Ann Intern Med. 1982;96:58-60.
39. Griner PF, El Badawi A, Packman CH. Veno-occlusive disease after chemotherapy of acute leukemia: report of two cases. Ann Intern Med. 1976;85: 578-582.
40. Krivoy N, Raz R, Carter A, et al. Reversible hepatic veno-occlusive disease and 6-thioguanine. Ann Intern Med. 1982;96:788.
41. Key NS, Kelly PMAQ, Emerson PM, et al. Oesophageal varices associated with busulfan-thioguanine combination therapy for chronic myeloid leukemia. Lancet. 1987;2:1050-1052.
42. Larrey D, Freneaux E, Berson A, et al. Peliosis hepatis caused by 6-thioguanine administration. Gut. 1988;29:1265-1269.
43. Milligan DW, Thein SL, Roberts BE. Secondary treatment of polycythemia rubra vera with 6-thioguanine. Cancer. 1982;50:836-839.
44. Satti MB, Weinbren K, Gordon-Smith EC. 6-Thioguanine as a cause of toxic veno-occlusive disease of the liver. J Clin Pathol. 1982;35:1086-1091.
45. Shepherd P, Harrison DJ. Idiopathic portal hypertension associated with cytotoxic drugs. J Clin Pathol. 1990;143:206-210.
46. Sznol M, Oknuma T, Holland JF. Hepatic toxicity of drugs used for hematologic neoplasms. Semin Liver Dis. 1987;7:237-256.
47. Zafrani ES, Pinadeau Y, Dhumeaux D. Drug-induced vascular lesions of the liver. Arch Intern Med. 1983;143:495-502.
48. Dubinsky MC, Hassard CV, Seidman EG, et al. An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy. Inflamm Bowel Dis. 2001;7:181-189.
49. McIlvanie SK, MacCarthy JD. Hepatitis in association with prolonged 6-mercaptopurine therapy. Blood. 1958;14:80-90.
50. Council on Drugs. Evaluation of two antineoplastic agents. JAMA. 1967; 200:619-620.
51. Jones RJ, Lee KS, Beshomer WE, et al. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation. 1987;4:778-783.
52. Wasser JS, Coleman M. Leukemia chemotherapy and centrilobular necrosis. Ann Intern Med. 1977;86:508-509.
53. Ranström S. Miliary hepatocellular adenomatosis. Acta Pathol Microbial Scand. 1953;33:225-229.
54. Jacobi A. N Y Med Review. 1897;52:109. Cited by: Ewing J. Neoplastic Diseases. 3rd ed. Philadelphia, Pa: WB Saunders; 1934:721.
55. Jacobi A. N Y Med Review. 1897;52:109. Cited by: Ewing J. Neoplastic Diseases. 3rd ed. Philadelphia, Pa: WB Saunders; 1934:721.
56. Dubinsky MC, Vasiliauskas EA, Singh M, et al. 6-Thioguanine (6-TG) can cause serious liver injury in inflammatory bowel disease (IBD) patients. Gastroenterology. 2003;125:298-303.
57. Petrovic LM. Benign hepatocellular tumors and tumor-like lesions. Pathology (Phila). 1994;3:119-139.
58. Trauner M, Stepan KM, Resch M, et al. Diagnostic problems in nodular regenerative hyperplasia (nodular transformation) of the liver. Z Gastroenterol. 1992;30:187-194.